Substitute House Bill 505 Summary

• Establishes definitions and regulations for "biological products" and "interchangeable biological products" under Ohio law, with automatic updates when federal FDA determinations change

• Allows pharmacists to substitute interchangeable biological products for prescribed biological products under specified conditions, similar to generic drug substitution rules

• Revises prior authorization deadlines for health insurers and medicaid: responses must be provided within 48 hours for urgent care or 10 calendar days for routine requests

• Requires 12-month prior authorization approval for chronic condition medications (with exceptions for controlled substances, trial medications, and other specified categories)

• Delays expiration of physician-physician assistant supervision agreements from January 31, 2017 to February 1, 2018, allowing renewals beginning August 1, 2017